Archives
-
Measuring Cancer Drug Responses In Vitro
2026-10-01
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these measures capture different relationships between proliferative arrest and cell death. The framework provides a more precise basis for interpreting in vitro drug responses and for designing assays that separate cytostatic effects from genuine cytotoxicity.
-
Vancomycin Workflows for Resistance Research
2026-10-01
Translate Vancomycin’s D-Ala-D-Ala binding into reproducible MRSA susceptibility, resistance, and controlled gut-microbiome experiments. This workflow emphasizes stock handling, broth microdilution design, comparator selection, and troubleshooting so antibiotic pressure is not mistaken for an immune or ecological effect.
-
(-)-Blebbistatin: Reliable Assay Workflows
2026-09-30
Learn how (-)-Blebbistatin, SKU B1387, can help distinguish non-muscle myosin II–dependent mechanical effects from genuine cytotoxicity in viability, proliferation, and cardiac assays. This scenario-based guide covers assay compatibility, dosing, solvent control, data interpretation, and practical vendor-selection criteria.
-
DNMT3B and Neuroendocrine Plasticity in Prostate Cancer
2026-09-30
The reference study identifies DNMT3B as a regulator of therapy-associated lineage plasticity, linking neuroendocrine differentiation with stemness in advanced prostate cancer. Genetic suppression and pharmacologic inhibition reduced neuroendocrine prostate cancer growth in preclinical models, supporting DNMT3B as a mechanistically motivated target rather than a passive disease marker.
-
Resazurin Sodium Salt in iPSC Drug Testing
2026-09-29
Resazurin sodium salt provides a redox-based viability readout that can strengthen iPSC-derived airway drug-testing workflows without being mistaken for a direct CFTR function assay. This guide explains how to integrate the fluorogenic oxidation-reduction indicator with multimodal cystic fibrosis models, control metabolic confounders, and improve interpretation.
-
Midecamycin In Vitro Activity: Methods and Findings
2026-09-29
Harold C. Neu’s 1983 study systematically characterized the in vitro spectrum of midecamycin across clinical isolates and compared it with erythromycin, β-lactams, and Vancomycin. The findings show useful activity against many streptococci, staphylococci, Haemophilus influenzae, and Listeria, but limited coverage of Enterobacteriaceae, Pseudomonas, and erythromycin-resistant organisms.
-
Blebbistatin Workflows for Cell Mechanics
2026-09-28
(±)-Blebbistatin enables reversible tests of non-muscle myosin II function in migration, adhesion, and morphology assays. This guide combines concentration planning with a spatially registered imaging strategy inspired by panoramic cardiac mapping, helping distinguish local cytoskeletal effects from global loss of cell health.
-
ZK53 and the Logic of Mitochondrial Stress
2026-09-28
ZK53 is a human mitochondrial serine protease ClpP activator for studying how mitochondrial proteostasis failure reshapes tumor-cell behavior. This article connects its established ClpP-driven effects to a distinct insight from fasting research: separating protein degradation from translational regulation when interpreting mitochondrial readouts.
-
Jasplakinolide Workflows for Actin Research
2026-09-27
Use Jasplakinolide to perturb actin assembly and filament stability in controlled, time-resolved experiments—not as a stand-in for normal cytoskeletal behavior. This practical guide covers titration, imaging, controls, and how to interpret a chemical-genetics study from a separate signaling field without conflating mechanisms.
-
Mechanical Stress–Induced Autophagy Depends on Cytoskeleton
2026-09-26
The study finds that microfilaments are required for compression-induced changes in autophagosome abundance, while microtubules make an auxiliary contribution. By pairing mechanical loading with cytoskeletal polymerization perturbations, it offers a framework for testing how cell structure participates in force-to-autophagy signaling, while leaving the specific molecular pathway and the distinction between autophagosome formation and turnover for further study.
-
Panoramic Hyperspectral Mapping of Cardiac Infarcts
2026-09-25
Kowalik and colleagues paired panoramic hyperspectral imaging with cardiac optical mapping to register epicardial tissue classes and membrane-potential activity across infarcted rat hearts. Their results associate infarct-border regions with premature ventricular contractions and reentrant activity, while showing how local tissue classification can add context to action-potential measurements.
-
RIPA Lysis Buffer Strong: Practical Protocol
2026-09-25
RIPA Lysis Buffer Strong supports detergent-based protein extraction from animal cells and tissues for workflows such as Western blotting and selected immunoassays. K1120 contains no protease or phosphatase inhibitors, so add appropriate inhibitors when target stability requires them; its strong detergent mixture may not suit workflows that require native protein complexes or detergent-sensitive reactions.
-
From Cardiac Maps to Cell Perturbation Logic
2026-09-24
Panoramic cardiac imaging shows why functional signals gain meaning when placed in their tissue context. This article translates that structure–function principle into practical cell-assay guidance for studying non-muscle myosin II with (±)-Blebbistatin—while making clear where the cross-domain analogy ends.
-
Griseofulvin Assays: Microtubule Mechanism & Workflow
2026-09-24
Griseofulvin helps researchers probe fungal mitosis and microtubule-associated effects, while a tiered flow-cytometry strategy can distinguish major aneugenic mechanisms in mammalian cells. This practical guide separates established study findings from suggested starting conditions and shows how to build interpretable, appropriately controlled assays.
-
Tyrothricin: Applied Antimicrobial Workflows
2026-09-23
Build a practical workflow around Tyrothricin, a peptide antibiotic mixture suited to exploratory antimicrobial and membrane-disruption studies. The guide separates screening from mechanism testing, with controls and troubleshooting designed to keep results interpretable.